No benefit of n-3 fatty acid supplements in diabetes
- PMID: 30214020
- DOI: 10.1038/s41569-018-0090-0
No benefit of n-3 fatty acid supplements in diabetes
Comment on
-
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.N Engl J Med. 2018 Oct 18;379(16):1540-1550. doi: 10.1056/NEJMoa1804989. Epub 2018 Aug 26. N Engl J Med. 2018. PMID: 30146932 Clinical Trial.
Similar articles
-
Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter?Cardiovasc Diabetol. 2018 Aug 28;17(1):119. doi: 10.1186/s12933-018-0766-0. Cardiovasc Diabetol. 2018. PMID: 30153832 Free PMC article.
-
[Target patients for polyunsaturated omega-3 fatty acids in cardiovascular disease prevention].Kardiol Pol. 2009 Nov;67(11):1299-303. Kardiol Pol. 2009. PMID: 20024861 Polish. No abstract available.
-
Omega-3 fatty acids: a comprehensive review of their role in health and disease.Postgrad Med J. 2009 Feb;85(1000):84-90. doi: 10.1136/pgmj.2008.073338. Postgrad Med J. 2009. PMID: 19329703 Review.
-
Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients.Singapore Med J. 2012 Sep;53(9):615-9. Singapore Med J. 2012. PMID: 23023905 Clinical Trial.
-
Omega-3 fatty acids for cystic fibrosis.Cochrane Database Syst Rev. 2011 Aug 10;(8):CD002201. doi: 10.1002/14651858.CD002201.pub3. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2013 Nov 27;(11):CD002201. doi: 10.1002/14651858.CD002201.pub4 PMID: 21833942 Updated. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical